Genetically modified pigs are valuable models of human disease and donors of xenotransplanted organs. Conventional gene targeting in pig somatic cells is extremely inefficient. Zinc-finger nuclease (ZFN) technology has been shown to be a powerful tool for efficiently inducing mutations in the genome. However, ZFN-mediated targeting in pigs has rarely been achieved. Here, we used ZFNs to knock out the porcine α-1,3-galactosyl-transferase (GGTA1) gene, which generates Gal epitopes that trigger hyperacute immune rejection in pig-to-human transplantation. Primary pig fibroblasts were transfected with ZFNs targeting the coding region of GGTA1. Eighteen mono-allelic and four biallelic knockout cell clones were obtained after drug selection with efficiencies of 23.4% and 5.2%, respectively. The biallelic cells were used to produce cloned pigs via somatic cell nuclear transfer (SCNT). Three GGTA1 null piglets were born, and one knockout primary fibroblast cell line was established from a cloned fetus. Gal epitopes on GGTA1 null pig cells were completely eliminated from the cell membrane. Functionally, GGTA1 knockout cells were protected from complement-mediated immune attacks when incubated with human serum. This study demonstrated that ZFN is an efficient tool in creating gene-modified pigs. GGTA1 null pigs and GGTA1 null fetal fibroblasts would benefit research and pig-to-human transplantation.
homologous recombination (HR) has only been shown to be efficient in embryonic stem (ES) cells [5, 6] . Unfortunately, to date, authentic pig ES cell lines have not been established. HR in cultured somatic cells is extremely inefficient, and this has become the main barrier in making gene-targeted pigs [3, 7, 8] . Recently, zinc-finger nuclease (ZFN) technology was shown to be a revolutionary tool for introducing targeted modifications into the genome.
Xenotransplantation is a potential approach to resolve the problem of human graft shortages in clinical allotransplantation. Thus far, pigs are the most appropriate animals for organ donation because of their compatible size and physiological characteristics with humans.
The cell membrane of most mammals presents α-1, 3-galactosyl (Gal) epitopes, with the exception of humans and Old World monkeys [9] . However, there are anti-Gal antibodies in human blood. Therefore, transplantation of pig organs into humans causes a hyperacute rejection response, which is a major barrier for pig-to-human transplantation [10] [11] [12] . Gal epitopes are catalyzed by α-1, 3-galactosyltransferase (GGTA1). Therefore, to eliminate the xenoantigen, the pig GGTA1 gene has been knocked out using conventional methods [8, 13] . Furthermore, solid organs from GGTA1 knockout pigs displayed significantly improved survival in pig-to-baboon xenotransplantation experiments [2, 4] . However, HR technology has low efficiency and introduces exogenous drug resistance genes.
Here, we report the generation of GGTA1 null pigs using ZFN technology.
Materials and methods

Generation of zinc-finger nucleases
The ZFN expression plasmids were obtained from Sigma Aldrich, USA. A total of three pairs of ZFNs targeting exon 4 and exon 6 of the porcine GGTA1 gene were designed and screened for activity in a yeast MEL-1 reporter assay. Initial activity evaluation of ZFNs in mammalian cells was performed using induced pluripotent stem (iPS) cells of pigs that were generated previously [14] . Pig iPS cells (5×10   5   ) were transfected with each pair of ZFN plasmids together with a plasmid carrying a puromycin resistance cassette using the FuGene HD transfection reagent (Roche, Switzerland). After selection with 1 μg mL 1 puromycin (Sigma, USA) for 3 d, the surviving cells were harvested and assayed by PCR of the GGTA1 locus with primers flanking the targeting sites. The PCR product was subcloned into the pEASY-Blunt Cloning Vector (Transgene, China) in accordance with the manufacturer's protocol. For each ZFN set, 50 colonies were picked and sequenced with the M13F primer. The targeting frequency was calculated as follows: mutant cell%=(number of mutant colonies/50)×100%×2.
Cell culture, transfection and selection
Fetal fibroblasts were isolated from porcine fetuses on day 35 of gestation as previously described and cultured for three passages in Dulbecco's Modified Eagle Medium (DMEM; GIBCO, USA) supplemented with 1% nonessential amino acids [15] . After electroporation, the cells were plated into five 10-cm dishes (NUNC, Denmark) for 2 d of culture in DMEM supplemented with 15% FBS, followed by a 2-week selection with G418 (500 μg mL 1 ). Cell colonies were picked using 10 mm×10 mm cloning cylinders (Sigma), passaged, and detected via PCR genotyping.
Somatic cell nuclear transfer and generation of cloned pigs
Somatic cell nuclear transfer (SCNT) was performed as previously described [16] . Biallelic knockout fibroblasts were cultured to sub-confluence before nuclear transfer. NT embryos cultured for 20 or 40 h were surgically transferred into surrogates. Gestation was monitored weekly via ultrasound starting 24 days after transfer. Two pregnancies were aborted on day 35 of gestation to establish fetal fibroblast cell lines [17] . The deliveries were performed by cesarean section on day 116120 of gestation. Ear tissue from the piglets was sampled for genotyping using the primers mentioned above. The PCR products were sequenced. Double curves in the sequence diagram usually indicate putative mutation.
Off-target site prediction
Off-targeting sites were searched by scanning the porcine genome using "The ZFN site," an online bioinformatic tool. The allowed spacing length was set at 5 or 6 bps, and two mismatches were permitted per half site of ZFN.
Isolectin staining
A total of 1×10 5 fibroblasts from 11LW5, G65P2, and G3F1 were harvested, washed, and incubated in 0.5 mL PBS with 1.5 μg FITC-conjugated isolectin-B4 (Enzo Life Sciences, Switzerland) for 5 min at 37°C. Subsequently, the cells were washed with PBS three times, plated in a single well of a 48-well plate, and examined immediately by fluorescence microscopy.
Complement-mediated lysis assay of porcine fibroblasts
An MTT assay and Trypan blue staining were performed to study the susceptibility of GGTA1 null cells from cloned piglets and fetuses to lysis by the human complement system. Porcine fibroblasts ( 2×10 5 ) were incubated in PBS with 10% pooled complement-preserved normal human serum (derived from a healthy volunteer) for 6 h. The treated cells were seeded onto a 96-well plate (NUNC) at 2×10 4 cells per well and cultured in DMEM supplemented with 15% FBS for 8 h. An MTT Cell proliferation and cytotoxicity assay kit (Beyotime, China) was used to evaluate cell activity in accordance with the manufacturer's protocol. Soluble formazan accumulation was detected with a spectrophotometer (SpectraMax M5 Multi-Mode Microplate Readers, Molecular Devices, USA) at a wavelength of 570 nm. Cell survival was calculated as follows: viable cell%=(absorptivity of human serum treated cells/absorptivity of non-treated cells)×100. For the Trypan blue staining assays, Trypan blue solution (Beyotime) was added to the treated cell suspensions at a final concentration of 0.04%. Three minutes later, both live and dead cells (stained as blue) were quantified and the mortality rate was calculated as follows: dead cell%=(number of dead cells/number of total cells) ×100.
Results
Creation of GGTA1 mutated porcine cells
Three pairs of ZFNs targeting the pig GGTA1 coding region were obtained commercially from Sigma Aldrich ( Figure  1A ). The efficiency of the ZFNs was tested in pig iPS cells previously generated by our laboratory. Only two pairs (Set#1 and Set#2) showed DNA cleavage activity, with efficiencies of 4.0% and 22.2%, respectively ( Figure 1B) . Therefore, the more active pair of ZFN (Set#2) plasmids that recognized exon 6 of GGTA1 was used to generate gene-targeted fibroblasts. ZFN plasmids together with pCDNA3.1-GFP plasmid were transfected into pig fetal fibroblasts via electroporation. After selection with G418, a total of 95 cell colonies were picked with cloning cylinders for further culture. Among them, 77 proliferated sufficiently and were therefore genotyped by sequencing the PCR product corresponding to the targeting site. We identified 18 clones carrying different mono-allelic mutations at the ZFN targeting site and four biallelic knockout cell clones ( Figure  1CE ).
To address off-targeting events of the ZFNs, an online bioinformatics tool, "The ZFN-site," was used to predict potential off-targeting sites by searching the pig genome. Fortunately, no off-target sites were predicted with the permission of two mismatches per half-site of GGTA1 with ZFN Set#2.
Generation of GGTA1 knockout piglets by somatic cell nuclear transfer
Three homozygous KO cell clones (G3, G12 and G65) ( Figure 1E ) were used as donor cells for SCNT. A total of 2093 cloned embryos were transferred into eleven surrogate mothers (Table 1) . Eight pigs were confirmed pregnant by ultrasonography. Among them, one surrogate mother aborted the pregnancy for unknown reasons. Two were sacrificed, and the fetuses were removed to establish serial GGTA1 knockout cell lines. The other five surrogate mothers gave birth to a total of 15 living piglets (Table 1) . Sequence analysis revealed that only three piglets were knockout individuals, derived from cell clones G12 (one piglet) and G65 (two piglets) (Figure 2A and B) . Unexpectedly, all nine piglets derived from cell clone G3 were not gene-modified. Therefore, we checked cell clone G3 for SCNT and found that the overwhelming majority of cells that were originally mutated were replaced by wild-type cells (data not shown). It was speculated that after several passages of amplification, the wild-type cells mixed with the knockout clones and became the predominant population due to impaired proliferation of the knockout cells.
Generation of fetal fibroblasts from GGTA1 knockout fetuses
It is generally considered that a pig requires multiple genetic modifications to be suitable for xenotransplantation. GGTA1 null mutants with modification of other immunerelated components would make pig organs much more compatible with human bodies [1821]. However, initiallytargeted fibroblasts nearly exhaust their proliferative capacity due to the long time required for drug selection and amplification. Therefore, it is necessary to obtain strongly proliferative GGTA1 null somatic cells from fetuses. In our study, two pregnant surrogate mothers were killed at day 35 (Table 1) , and nine morphologically normal fetuses (G3F1- Figure 2 Generation of GGTA1 knockout cloned pigs and primary fibroblasts derived from cloned fetuses. A, DNA and amino acid sequences of GGTA1 proximal to the ZFN targeting site in the biallelic knockout cell clones used for SCNT. The yellow highlighted region indicates the space of the ZFNs. B, Image of GGTA1 null cloned piglets at four weeks of age. C, Primary fibroblasts isolated from the cloned fetus G3F1. Scale bar, 100 μL.
G3F9) were obtained, from which primary fibroblasts were successfully isolated and cultured ( Figure 2C ). Sequencing analysis confirmed G3F1 as a knockout fetus in accordance with the donor cell clone G3 (Figure 2A ).
Gal epitopes were eliminated in fibroblasts derived from GGTA1 null piglets and fetuses
Isolectin B4 shows high affinity toward alpha galactose on cell membranes [22, 23] . Hence, FITC-conjugated isolectin B4 was used to detect Gal epitopes of GGTA1 mutant porcine cells. In our study, isolectin B4 staining showed the absence of Gal epitopes on G65P2 and G3F1 cells, which were derived from GGTA1 null cloned piglets and fetuses, respectively. On the other hand, wild-type primary fibroblasts (11LW5) exhibited obvious green fluorescence on their cell surfaces, indicating Gal epitopes ( Figure 3A ).
GGTA1 biallelic mutation protects porcine fibroblasts from complement-mediated lysis
To study whether depletion of Gal epitopes prevents cell lysis by the human complement system, GGTA1 null fibroblasts from cloned piglets (G65P2) and from cloned fetuses (G3F1), as well as wild-type fibroblasts (11LW5), were treated with complete human serum. Trypan blue staining and MTT assays were performed to detect cell survival after immune attack. Trypan blue stains dead cells while MTT assays label live cells. By treating the cells with a 1 : 10 dilution of human serum for 6 h, 88.2% of the wild-type cells were killed. However, the GGTA1 null cells (G65P2 and G3F1) only showed approximately 18% cell death ( Figure  3B) . Similarly, the MTT assays also demonstrated that few 11LW5 cells survived after human serum treatment. On the other hand, GGTA1 null fibroblasts showed nearly full activity, indicated by an accumulation of formazan ( Figure  3C ). These results convincingly showed that the elimination of Gal epitopes by ZFN-mediated GGTA1 knockout efficiently protected pig somatic cells from human complement-mediated lysis.
Discussion
In this study, we demonstrated that ZFN technology was capable of efficiently disrupting GGTA1 gene in porcine somatic cells. Moreover, biallelic knockout piglets were successfully produced via SCNT using ZFN-targeted cells. Fibroblasts derived from GGTA1 null cloned piglets and fetuses lacked Gal epitopes and showed dramatic resistance against human complement-mediated lysis, as described in previous reports. Due to their physiological and anatomical similarities with humans, pigs are considered to be a better experimental model than rodents and one of the best donors for organ transplantation. However, precise genetic modification of pigs is quite difficult due to the absence of ES cells, which dramatically hampers the use of pigs in biomedical research and drug discovery. In our current study, we demonstrated that ZFN-mediated targeting has an efficiency 10000-fold higher than that of conventional HR targeting technology. Furthermore, biallelic knockout could be achieved in primary cells with a frequency of 5.2%, which Figure 3 Gal epitope detection and complement-mediated lysis of porcine ZFN-GGTA1 knockout fibroblasts. A, Isolectin B4-FITC-staining of fibroblasts from wild-type pigs, knockout cloned piglets and fetuses. B, Trypan blue assay of GGTA1 knockout fibroblasts treated with human serum. C, MTT assay of GGTA1 knockout fibroblasts treated with human serum. 11LW5 is a wild-type porcine fibroblast line, while G65P2 and G3F1 are fibroblasts derived from GGTA1 knockout cloned piglets and fetuses, respectively. means that genetically deficient pigs could be generated from a single cloning step. During the process of our study, similar progress had been made by other groups, who also demonstrated the efficient generation of ZFN-mediated GGTA1 knockout pigs via SCNT [24, 25] .
Previous studies found that GGTA1 knockout reduced immune rejection, but this strategy could not completely eliminate immune rejection in xenotransplantation. Several improvements have been made to prolong xenograft survival, such as ectopic expression of human complement regulatory proteins (CD46, CD55, or CD59). Because of their limited proliferation ability, genetically modified pig primary cells are difficult to expand for further genetic manipulation. In the current study, we isolated primary fibroblasts from GGTA1 null fetuses. These cells allowed additional genetic modification based on GGTA1 knockout and improved our understanding of pig-to-human organ transplantation.
